Penny Stocks

The latest company news is the third-quarter 2026 report, released ahead of the October 29, 2026 earnings call. Investors may be responding to that report's margin gains and automation growth, or to a wider small cap bounce, but neither explanation has been verified.

No company announcement dated November 2 to November 4, 2026 was identified, so no confirmed catalyst exists. The most recent filings found were the notice that an extraordinary general meeting was adjourned on September 21, 2026 for lack of a quorum and the announcement …

Curis (NASDAQ:CRIS) was up 83.54%, or USD 0.5964, to USD 1.3103 in pre-market trading on November 4, 2026. No company press release, filing or clinical update dated November 2 to November 4, 2026 was identified, so the rise looks like speculative momentum.

The more relevant disclosure is a sales agreement dated October 9, 2026 allowing up to USD 100 million of common stock to be offered over time. Full year 2025 revenue was USD 18.08 million, down about 42%, with a net loss of about USD …

Cash was USD 5.1 million at June 30, 2026, down from USD 15.0 million at March 31, and the first half net loss was USD 32.8 million. A 1-for-20 reverse split took effect on July 2, 2026, and an August offering raised about USD …

Darkiris (NASDAQ:DKI) rose 55.30%, or USD 0.8297, to USD 2.33 in pre-market trading on November 4, 2026, implying a Tuesday close of about USD 1.5003 (calculated). No press release, regulatory filing orEarningsreport dated November 2 to November 4, 2026 was identified, so the move …

Shares outstanding would decline from 31,949,758 to roughly 550,858. Preliminary third quarter continuing operationsRevenuecame to about USD 4.8 million, compared with USD 2.9 million in the second quarter. These figures are unaudited and may change. Cash of USD 3.9 million set against a USD …